PANADOLExtra (GlaxoSmithKline Consumer Healthcare Holdings (US) LLC)
Welcome to the PulseAid listing for the PANADOL drug offered from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| NON-PROPRIETARY NAME: | acetaminophen and caffeine |
| SUBSTANCE NAME: | ACETAMINOPHEN; CAFFEINE |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
| START MARKETING DATE: | 2017-03-01 |
| END MARKETING DATE: | 0000-00-00 |
PANADOL Extra HUMAN OTC DRUG Details:
| Item Description | PANADOL Extra from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| LABELER NAME: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500; 65(mg/1; mg/1) |
| START MARKETING DATE: | 2017-03-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0135-0620_e5c2d88a-d903-4ca0-b895-f27e791dfc4e |
| PRODUCT NDC: | 0135-0620 |
| APPLICATION NUMBER: | part343 |
Other ACETAMINOPHEN; CAFFEINE Pharmaceutical Manufacturers / Labelers:
